Gene Discovery May Move Personalized Stomach Cancer Treatment Forward

<p>SUNDAY, Apr 8 (HealthDay News) — An general group of
researchers has identified hundreds of new genes that are deteriorated in<span>stomach cancer</span>, in a anticipating they contend could lead to treatments tailored to
the genetic make-up of particular stomach tumors.</p>
<p>Stomach cancer is a second heading means of <span>cancer</span> genocide worldwide
and kills some-more than 700,000 people a year, according to a World Health
Organization. Treatment is mostly formidable and unsuccessful. In a United
States, reduction than one-quarter of stomach cancer patients tarry some-more than
five years after diagnosis.</p>
<p>“Until now, a genetic abnormalities that means stomach cancers are
still mostly unknown, that partially explain a altogether bad treatment
outcome,” pronounced a study’s comparison author, Dr. Patrick Tan, an associate
professor in a Cancer and Stem Cell Biology Program during Duke-NUS Graduate
Medical School,...